Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform - BioSpace
Johnson & Johnson→Firefly Bio
Jun 9, 2026
Elis has acquired RS10 Servicios Tratamientos y mantenimientos de Tejidos, a healthcare services other business in Spain. Elis acquisitions expand into RS10’s modern laundry and linen maintenance operations in the north-east of Barcelona, serving healthcare clients and also hospitality and foodservice customers. RS10 provides flat linen and workwear rental-maintenance services with about 90 employees, supporting hygiene and protection needs. The strategic acquisition is an add on acquisition for Elis, with RS10 revenue of €5.5 million in 2025 and consolidation expected from June 1, 2026.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Johnson & Johnson→Firefly Bio
Jun 9, 2026
Galmed→Colospan
Jun 9, 2026
Standard BioTools
Jun 9, 2026
Incyte→Vega Therapeutics
Jun 8, 2026
Angelini Pharma→Catalyst Pharmaceuticals
Jun 8, 2026